WO2023216521A1 - Surface modification method for degradable pure magnesium or magnesium alloy, and pure magnesium or magnesium alloy material - Google Patents
Surface modification method for degradable pure magnesium or magnesium alloy, and pure magnesium or magnesium alloy material Download PDFInfo
- Publication number
- WO2023216521A1 WO2023216521A1 PCT/CN2022/128189 CN2022128189W WO2023216521A1 WO 2023216521 A1 WO2023216521 A1 WO 2023216521A1 CN 2022128189 W CN2022128189 W CN 2022128189W WO 2023216521 A1 WO2023216521 A1 WO 2023216521A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- magnesium
- magnesium alloy
- pure
- pure magnesium
- surface modification
- Prior art date
Links
- 229910000861 Mg alloy Inorganic materials 0.000 title claims abstract description 119
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims abstract description 105
- 229910052749 magnesium Inorganic materials 0.000 title claims abstract description 105
- 239000011777 magnesium Substances 0.000 title claims abstract description 105
- 239000000956 alloy Substances 0.000 title claims abstract description 16
- 238000002715 modification method Methods 0.000 title claims abstract description 14
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 26
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910052802 copper Inorganic materials 0.000 claims abstract description 26
- 239000010949 copper Substances 0.000 claims abstract description 26
- 238000002347 injection Methods 0.000 claims abstract description 26
- 239000007924 injection Substances 0.000 claims abstract description 26
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 26
- 239000011701 zinc Substances 0.000 claims abstract description 26
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 20
- 239000001301 oxygen Substances 0.000 claims abstract description 19
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000011248 coating agent Substances 0.000 claims abstract description 11
- 238000000576 coating method Methods 0.000 claims abstract description 11
- 239000007789 gas Substances 0.000 claims abstract description 11
- 238000005468 ion implantation Methods 0.000 claims abstract description 11
- 239000007943 implant Substances 0.000 claims description 17
- 230000004048 modification Effects 0.000 claims description 13
- 238000012986 modification Methods 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 6
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 3
- 150000002910 rare earth metals Chemical class 0.000 claims description 3
- PGTXKIZLOWULDJ-UHFFFAOYSA-N [Mg].[Zn] Chemical class [Mg].[Zn] PGTXKIZLOWULDJ-UHFFFAOYSA-N 0.000 claims 1
- XVYHFPMIBWTTLH-UHFFFAOYSA-N [Zn].[Mg].[Ca] Chemical class [Zn].[Mg].[Ca] XVYHFPMIBWTTLH-UHFFFAOYSA-N 0.000 claims 1
- 238000005260 corrosion Methods 0.000 abstract description 13
- 230000007797 corrosion Effects 0.000 abstract description 13
- 208000035143 Bacterial infection Diseases 0.000 abstract description 6
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 6
- 150000002500 ions Chemical class 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000003013 cytotoxicity Effects 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- 239000005751 Copper oxide Substances 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- GRWTXBFSMVOHIF-UHFFFAOYSA-N [Ca].[Mg].[Zn].[Mg] Chemical compound [Ca].[Mg].[Zn].[Mg] GRWTXBFSMVOHIF-UHFFFAOYSA-N 0.000 description 2
- QAAFWYAPYNNVNJ-UHFFFAOYSA-N [Mg].[Mg].[Zn] Chemical compound [Mg].[Mg].[Zn] QAAFWYAPYNNVNJ-UHFFFAOYSA-N 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 229910000431 copper oxide Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 206010066902 Surgical failure Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
- C23C14/48—Ion implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/06—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the coating material
- C23C14/14—Metallic material, boron or silicon
- C23C14/16—Metallic material, boron or silicon on metallic substrates or on substrates of boron or silicon
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/58—After-treatment
- C23C14/5846—Reactive treatment
- C23C14/5853—Oxidation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
Definitions
- the invention relates to the technical field of metal surface modification, and in particular to a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials.
- pure magnesium and magnesium alloys Due to the excellent biocompatibility of pure magnesium and magnesium alloys, and their comprehensive mechanical properties such as elastic modulus are close to those of human bones, pure magnesium and magnesium alloys have attracted more and more attention in the fields of biomedicine and other fields. Pure magnesium and magnesium alloys are degradable.
- the use of magnesium's tendency to corrode in the human environment is used to achieve the medical and clinical purpose of gradually biodegrading pure magnesium and magnesium alloy implants in the body until they eventually disappear, unlike traditional metal implants. In comparison, secondary removal surgery can be avoided and the patient's mental and financial burden can be reduced.
- pure magnesium and magnesium alloys degrade too quickly. However, rapid corrosion and degradation in physiological environments often cause the tissue to fail before it heals, losing the fixation and support of the injured part, affecting the repair and maintenance of the tissue. heal.
- pure magnesium and magnesium alloys themselves have no biological functions and are prone to infection after implantation. Bacterial infection caused by implants is one of the key factors leading to surgical failure. Foreign matter disrupts the normal operating system of the body and can easily destroy the body’s defense barrier, increasing The chance of retrograde infection. Infection caused by implants is very difficult and the incidence rate remains high. It brings huge physical pain and heavy economic burden to patients, and at the same time limits the widespread application of implanted devices.
- the embodiment of the present invention discloses a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials, which are used to solve the problem that the existing medical pure magnesium or magnesium alloy materials are not corrosion-resistant and easy to be implanted into the human body.
- Technical problem of bacterial infection is a problem that the existing medical pure magnesium or magnesium alloy materials are not corrosion-resistant and easy to be implanted into the human body.
- the embodiment of the present invention provides a method for surface modification of degradable pure magnesium or magnesium alloy, including the following steps:
- step S3 Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2;
- a coating containing copper and zinc elements is formed on the surface of pure magnesium or magnesium alloy.
- the preprocessing in step S1 includes:
- Pure magnesium or magnesium alloy is polished, ultrasonic cleaned and dried in sequence.
- step S2 specifically includes:
- the pulse voltage is -5 ⁇ -35kV
- the injection pressure is 1 ⁇ 3 ⁇ 10 -3 Pa
- the injection time is 1 ⁇ 3h.
- step S3 specifically includes:
- the pulse voltage is -5 ⁇ -35kV
- the injection pressure is 1 ⁇ 3 ⁇ 10-3 Pa
- the injection time is 1 ⁇ 3h.
- step S4 specifically includes:
- step S3 oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150 ⁇ s, pulse frequency 50Hz, processing time 1 to 2 hours.
- the magnesium alloy is one of a magnesium-zinc-calcium magnesium alloy, a magnesium-zinc magnesium alloy, and a rare earth magnesium alloy.
- step S6 is also included;
- An embodiment of the present invention provides a pure magnesium or magnesium alloy material, which is characterized in that it is obtained by using the above-mentioned degradable pure magnesium or magnesium alloy surface modification method.
- copper elements and zinc elements are injected into the surface of pure magnesium or magnesium alloy through ion implantation, so that a coating containing copper elements and zinc elements is formed on the surface of pure magnesium or magnesium alloy.
- copper Elements, zinc and oxygen form a thin film of zinc oxide and copper oxide on the surface of pure magnesium or magnesium alloy, which can greatly improve the stability of pure magnesium or magnesium alloy and at the same time improve the corrosion resistance of pure magnesium or magnesium alloy.
- the zinc ions and copper ions released by the above coating can play a bactericidal effect and avoid bacterial infection.
- Figure 1 is a flow chart of a surface modification method for degradable pure magnesium or magnesium alloys.
- the embodiment of the present invention discloses a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials, which are used to solve the problem that the existing medical pure magnesium or magnesium alloy materials are not corrosion-resistant and easy to be implanted into the human body.
- Technical problem of bacterial infection is a problem that the existing medical pure magnesium or magnesium alloy materials are not corrosion-resistant and easy to be implanted into the human body.
- a method for surface modification of degradable pure magnesium or magnesium alloy provided in an embodiment of the present invention includes the following steps:
- step S3 Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2;
- a coating containing copper and zinc elements is formed on the surface of pure magnesium or magnesium alloy.
- copper elements and zinc elements are injected into the surface of pure magnesium or magnesium alloy through ion implantation, so that a coating containing copper elements and zinc elements is formed on the surface of pure magnesium or magnesium alloy.
- a gas injector After oxygen, the copper element, zinc element and oxygen element form a layer of zinc oxide and copper oxide film on the surface of pure magnesium or magnesium alloy, which can greatly improve the stability of pure magnesium or magnesium alloy and at the same time improve the stability of pure magnesium or magnesium alloy.
- the corrosion resistance of pure magnesium or magnesium alloy effectively slows down the degradation rate of pure magnesium or magnesium alloy. As the degradation process of pure magnesium or magnesium alloy proceeds, the zinc ions and copper ions released by the above coating can play a bactericidal effect and avoid bacterial infection.
- step S1 includes:
- Pure magnesium or magnesium alloy is polished, ultrasonic cleaned and dried in sequence.
- step S2 specifically includes:
- the pulse voltage is -5 ⁇ -35kV
- the injection pressure is 1 ⁇ 3 ⁇ 10 -3 Pa
- the injection time is 1 ⁇ 3h.
- step S3 specifically includes:
- the pulse voltage is -5 ⁇ -35kV
- the injection pressure is 1 ⁇ 3 ⁇ 10-3 Pa
- the injection time is 1 ⁇ 3h.
- step S4 specifically includes:
- step S3 oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150 ⁇ s, pulse frequency 50Hz, processing time 1 to 2 hours.
- the magnesium alloy is one of a magnesium-zinc-calcium magnesium alloy, a magnesium-zinc magnesium alloy, and a rare earth magnesium alloy.
- this embodiment does not limit the specific type of magnesium alloy, and designers can select a suitable magnesium alloy for surface modification according to actual conditions.
- step S6 Also includes step S6;
- the degradable pure magnesium or magnesium alloy material provided in the embodiment of the present invention is specifically obtained by using the degradable pure magnesium or magnesium alloy surface modification method described in Embodiment 1.
- the pure magnesium or magnesium alloy material modified by the surface modification method in this embodiment has good biological safety, excellent mechanical properties, corrosion resistance and antibacterial properties, and can meet the requirements of implant materials. Use requirements, and can be degraded and disappeared after achieving the use effect in the matrix, avoiding secondary surgical removal.
- pure magnesium is cut into discs with a diameter of 10mm and a thickness of 3mm, and the surface is polished, polished, ultrasonic cleaned and dried in sequence.
- Pure magnesium discs were ion implanted using a metal ion implanter equipped with a zinc cathode arc source.
- the pulse voltage was -15kV
- the injection pressure was 1 ⁇ 10 -3 Pa
- the injection time was 1 hour.
- a metal ion implanter equipped with a copper cathode arc source was used to implant ions into the pure magnesium wafer.
- the pulse voltage was -15kV
- the injection pressure was 1 ⁇ 10 -3 Pa
- the injection time was 1 hour.
- oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150 ⁇ s, pulse frequency 50Hz, processing time 1h.
- the Mg-2Zn-0.8Ca magnesium alloy was cut into discs with a diameter of 10mm and a thickness of 3mm, and the surface was polished, polished, ultrasonic cleaned and dried in sequence.
- a metal ion implanter equipped with a zinc cathode arc source was used to implant ions into the above-mentioned magnesium alloy discs.
- the pulse voltage was -15kV
- the injection pressure was 1 ⁇ 10 -3 Pa
- the injection time was 2h.
- a metal ion implanter equipped with a copper cathode arc source was used to implant ions into the magnesium alloy wafer.
- the pulse voltage was -15kV
- the injection pressure was 1 ⁇ 10 -3 Pa
- the injection time was 2h.
- oxygen flow 30sccm oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150 ⁇ s, pulse frequency 50Hz, processing time 1h.
- the corrosion resistance of the magnesium alloy discs in this experimental example is shown in Table 1, and the antibacterial rate and cytotoxicity are shown in Table 2.
- the Mg-1Zn-0.2Nd-1Zr magnesium alloy was cut into discs with a diameter of 10mm and a thickness of 3mm, and the surface was polished, polished, ultrasonic cleaned and dried in sequence.
- a metal ion implanter equipped with a zinc cathode arc source was used to implant ions into magnesium alloy discs.
- the pulse voltage was -15kV
- the injection pressure was 1 ⁇ 10 -3 Pa
- the injection time was 1.5h.
- a metal ion implanter equipped with a copper cathode arc source was used to implant ions into the pure magnesium wafer.
- the pulse voltage was -15kV
- the injection pressure was 1 ⁇ 10 -3 Pa
- oxygen flow 30sccm oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150 ⁇ s, pulse frequency 50Hz, processing time 1h.
- the corrosion resistance of the magnesium alloy discs in this experimental example is shown in Table 1, and the antibacterial rate and cytotoxicity are shown in Table 2.
- Table 1 Annual corrosion rate of pure magnesium discs and magnesium alloy discs soaked in Hanks solution for 30 days in each experimental example
- the pure magnesium or magnesium alloy material modified by the surface modification method of the present invention has good corrosion resistance and excellent antibacterial properties. It can meet the requirements for the use of implant materials, and can degrade and disappear after achieving the use effect in the matrix, avoiding secondary surgical removal.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physical Vapour Deposition (AREA)
Abstract
The embodiments of the present invention disclose a surface modification method for degradable pure magnesium or a degradable magnesium alloy, and a pure magnesium or magnesium alloy material, so as to solve the technical problems whereby an existing medical pure magnesium or magnesium alloy material is not resistant to corrosion and prone to bacterial infection after being implanted into a human body. The method in the embodiments of the present invention comprises the following steps: S1, pretreating pure magnesium or a magnesium alloy; S2, subjecting the pure magnesium or magnesium alloy to ion implantation by means of a metal ion implanter provided with a zinc cathode arc source; S3, subjecting the pure magnesium or magnesium alloy obtained after step S2 is completed to ion implantation by means of a metal ion implanter provided with a copper cathode arc source; S4, subjecting the pure magnesium or magnesium alloy obtained after step S3 is completed to oxygen injection by means of a gas injection machine; and S5, forming a coating, which contains copper and zinc, on the surface of the pure magnesium or magnesium alloy.
Description
本申请要求于2022年05月07日提交中国专利局、申请号为202210493489.5、发明名称为“一种可降解纯镁或镁合金表面改性方法及纯镁或镁合金材料”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application is required to be submitted to the China Patent Office on May 7, 2022, with the application number 202210493489.5 and the invention title being "A degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy material". priority, the entire contents of which are incorporated into this application by reference.
本发明涉及金属表面改性技术领域,尤其涉及一种可降解纯镁或镁合金表面改性方法及纯镁或镁合金材料。The invention relates to the technical field of metal surface modification, and in particular to a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials.
由于纯镁和镁合金优异的生物相容性,及其弹性模量等综合力学性能与人体骨骼接近,因此,纯镁和镁合金在生物医学等领域受到人们越来越多的关注。纯镁和镁合金是可降解的,利用镁在人体环境中易发生腐蚀的特性,来实现纯镁和镁合金植入物在体内逐渐生物降解直至最终消失的医学临床目的,与传统植入金属相比,可避免二次取出手术,减轻患者的精神和经济负担。Due to the excellent biocompatibility of pure magnesium and magnesium alloys, and their comprehensive mechanical properties such as elastic modulus are close to those of human bones, pure magnesium and magnesium alloys have attracted more and more attention in the fields of biomedicine and other fields. Pure magnesium and magnesium alloys are degradable. The use of magnesium's tendency to corrode in the human environment is used to achieve the medical and clinical purpose of gradually biodegrading pure magnesium and magnesium alloy implants in the body until they eventually disappear, unlike traditional metal implants. In comparison, secondary removal surgery can be avoided and the patient's mental and financial burden can be reduced.
但是纯镁和镁合金存在降解速率太快,然而生理环境下的快速腐蚀降解,往往使其在组织未愈合前就发生失效,失去了对受伤部位的固定和支撑作用,影响了组织的修复和愈合。另外,纯镁和镁合金本身没有生物学功能,植入后易感染,植入物引发的细菌感染是导致手术失败的关键因素之一,异物扰乱体内正常运转系统,容易破坏机体防御屏障,增加逆行感染的机会,由植入物引发的感染非常棘手,发病率居高不下,给患者带来巨大的生理痛苦和沉重的经济负担,同时限制了植入器械的广泛应用。However, pure magnesium and magnesium alloys degrade too quickly. However, rapid corrosion and degradation in physiological environments often cause the tissue to fail before it heals, losing the fixation and support of the injured part, affecting the repair and maintenance of the tissue. heal. In addition, pure magnesium and magnesium alloys themselves have no biological functions and are prone to infection after implantation. Bacterial infection caused by implants is one of the key factors leading to surgical failure. Foreign matter disrupts the normal operating system of the body and can easily destroy the body’s defense barrier, increasing The chance of retrograde infection. Infection caused by implants is very difficult and the incidence rate remains high. It brings huge physical pain and heavy economic burden to patients, and at the same time limits the widespread application of implanted devices.
因此,寻找一种能够解决上述技术问题的可降解纯镁或镁合金表面改性方法及纯镁或镁合金材料成为本领域技术人员所研究的重要课题。Therefore, finding a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials that can solve the above technical problems has become an important research topic for those skilled in the art.
发明内容Contents of the invention
本发明实施例公开了一种可降解纯镁或镁合金表面改性方法及纯镁或镁合金材料,用于解决现有的医用纯镁或镁合金材料在植入人体后不耐腐蚀且容易发生细菌感染的技术问题。The embodiment of the present invention discloses a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials, which are used to solve the problem that the existing medical pure magnesium or magnesium alloy materials are not corrosion-resistant and easy to be implanted into the human body. Technical problem of bacterial infection.
本发明实施例提供了一种可降解纯镁或镁合金表面改性方法,包括以下步 骤:The embodiment of the present invention provides a method for surface modification of degradable pure magnesium or magnesium alloy, including the following steps:
S1、将纯镁或镁合金进行预处理;S1. Preprocess pure magnesium or magnesium alloy;
S2、采用配备锌阴极弧源的金属离子注入机对纯镁或镁合金进行离子注入;S2. Use a metal ion implanter equipped with a zinc cathode arc source to perform ion implantation on pure magnesium or magnesium alloy;
S3、采用配备铜阴极弧源的金属离子注入机对完成步骤S2的纯镁或镁合金进行离子注入;S3. Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2;
S4、使用气体注入机对完成步骤S3的纯镁或镁合金进行氧气注入;S4. Use a gas injector to inject oxygen into the pure magnesium or magnesium alloy that has completed step S3;
S5、纯镁或镁合金表面形成含铜元素和锌元素的涂层。S5. A coating containing copper and zinc elements is formed on the surface of pure magnesium or magnesium alloy.
可选地,所述步骤S1中的预处理包括:Optionally, the preprocessing in step S1 includes:
对纯镁或者镁合金依次进行抛光处理、超声清洗和干燥。Pure magnesium or magnesium alloy is polished, ultrasonic cleaned and dried in sequence.
可选地,所述步骤S2具体包括:Optionally, the step S2 specifically includes:
采用配备锌阴极弧源的金属离子注入机对纯镁或镁合金进行离子注入,脉冲电压为-5~-35kV,注入压力为1~3×10
-3Pa,注入时间为1~3h。
Use a metal ion implanter equipped with a zinc cathode arc source to perform ion implantation on pure magnesium or magnesium alloy. The pulse voltage is -5~-35kV, the injection pressure is 1~3×10 -3 Pa, and the injection time is 1~3h.
可选地,所述步骤S3具体包括:Optionally, the step S3 specifically includes:
采用配备铜阴极弧源的金属离子注入机对完成步骤S2的纯镁或镁合金进行离子注入,脉冲电压为-5~-35kV,注入压力为1~3×10
-3Pa,注入时间为1~3h。
Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2. The pulse voltage is -5~-35kV, the injection pressure is 1~3× 10-3 Pa, and the injection time is 1 ~3h.
可选地,所述步骤S4具体包括:Optionally, the step S4 specifically includes:
使用气体注入机对完成步骤S3的纯镁或镁合金进行氧气注入:氧气流量30sccm,射频1000W,脉冲电压-20kV,脉宽150μs,脉冲频率50Hz,处理时间1~2h。Use a gas injector to inject oxygen into the pure magnesium or magnesium alloy that has completed step S3: oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150μs, pulse frequency 50Hz, processing time 1 to 2 hours.
可选地,所述的镁合金为镁锌钙系镁合金、镁锌系镁合金、稀土系镁合金中的一种。Optionally, the magnesium alloy is one of a magnesium-zinc-calcium magnesium alloy, a magnesium-zinc magnesium alloy, and a rare earth magnesium alloy.
可选地,还包括步骤S6;Optionally, step S6 is also included;
S6、对形成含铜元素和锌元素的涂层的纯镁或镁合金进行清洗,再吹干保存。S6. Clean the pure magnesium or magnesium alloy that forms the coating containing copper elements and zinc elements, and then blow dry and store it.
本发明实施例提供了一种纯镁或镁合金材料,其特征在于,采用上述的可降解纯镁或镁合金表面改性方法得到。An embodiment of the present invention provides a pure magnesium or magnesium alloy material, which is characterized in that it is obtained by using the above-mentioned degradable pure magnesium or magnesium alloy surface modification method.
从以上技术方案可以看出,本发明实施例具有以下优点:It can be seen from the above technical solutions that the embodiments of the present invention have the following advantages:
本实施例中,通过离子注入法将铜元素和锌元素注入到纯镁或镁合金的表 面,使得纯镁或镁合金的表面形成含铜元素和锌元素的涂层,在氧气环境下,铜元素、锌元素和氧元素在纯镁或镁合金表面形成一层氧化锌和氧化铜薄膜,能够大大提高的纯镁或镁合金的稳定性的同时又能提高纯镁或镁合金的耐腐蚀性,有效减缓纯镁或镁合金的降解速率,并且随着纯镁或镁合金降解过程的进行,上述涂层所释放的锌离子和铜离子可起到杀菌作用,避免细菌感染。In this embodiment, copper elements and zinc elements are injected into the surface of pure magnesium or magnesium alloy through ion implantation, so that a coating containing copper elements and zinc elements is formed on the surface of pure magnesium or magnesium alloy. In an oxygen environment, copper Elements, zinc and oxygen form a thin film of zinc oxide and copper oxide on the surface of pure magnesium or magnesium alloy, which can greatly improve the stability of pure magnesium or magnesium alloy and at the same time improve the corrosion resistance of pure magnesium or magnesium alloy. , effectively slowing down the degradation rate of pure magnesium or magnesium alloy, and as the degradation process of pure magnesium or magnesium alloy proceeds, the zinc ions and copper ions released by the above coating can play a bactericidal effect and avoid bacterial infection.
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其它的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the drawings needed to be used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings in the following description are only These are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can be obtained based on these drawings without exerting any creative effort.
图1为一种可降解纯镁或镁合金表面改性方法的流程图。Figure 1 is a flow chart of a surface modification method for degradable pure magnesium or magnesium alloys.
本发明实施例公开了一种可降解纯镁或镁合金表面改性方法及纯镁或镁合金材料,用于解决现有的医用纯镁或镁合金材料在植入人体后不耐腐蚀且容易发生细菌感染的技术问题。The embodiment of the present invention discloses a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials, which are used to solve the problem that the existing medical pure magnesium or magnesium alloy materials are not corrosion-resistant and easy to be implanted into the human body. Technical problem of bacterial infection.
为了使本技术领域的人员更好地理解本发明方案,下面结合附图和具体实施方式对本发明作进一步的详细说明。显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to enable those skilled in the art to better understand the solution of the present invention, the present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments. Obviously, the described embodiments are only some of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts fall within the scope of protection of the present invention.
实施例一Embodiment 1
请参阅图1,本发明实施例中提供的一种可降解纯镁或镁合金表面改性方法,包括以下步骤:Please refer to Figure 1. A method for surface modification of degradable pure magnesium or magnesium alloy provided in an embodiment of the present invention includes the following steps:
S1、将纯镁或镁合金进行预处理;S1. Preprocess pure magnesium or magnesium alloy;
S2、采用配备锌阴极弧源的金属离子注入机对纯镁或镁合金进行离子注入;S2. Use a metal ion implanter equipped with a zinc cathode arc source to perform ion implantation on pure magnesium or magnesium alloy;
S3、采用配备铜阴极弧源的金属离子注入机对完成步骤S2的纯镁或镁合金进行离子注入;S3. Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2;
S4、使用气体注入机对完成步骤S3的纯镁或镁合金进行氧气注入;S4. Use a gas injector to inject oxygen into the pure magnesium or magnesium alloy that has completed step S3;
S5、纯镁或镁合金表面形成含铜元素和锌元素的涂层。S5. A coating containing copper and zinc elements is formed on the surface of pure magnesium or magnesium alloy.
本实施例中,通过离子注入法将铜元素和锌元素注入到纯镁或镁合金的表面,使得纯镁或镁合金的表面形成含铜元素和锌元素的涂层,在被气体注入机注入氧气后,铜元素、锌元素和氧元素在纯镁或镁合金表面形成一层氧化锌和氧化铜薄膜,能够大大提高的纯镁或镁合金的稳定性的同时又能提高纯镁或镁合金的耐腐蚀性,有效减缓纯镁或镁合金的降解速率,并且随着纯镁或镁合金降解过程的进行,上述涂层所释放的锌离子和铜离子可起到杀菌作用,避免细菌感染。In this embodiment, copper elements and zinc elements are injected into the surface of pure magnesium or magnesium alloy through ion implantation, so that a coating containing copper elements and zinc elements is formed on the surface of pure magnesium or magnesium alloy. After being injected by a gas injector, After oxygen, the copper element, zinc element and oxygen element form a layer of zinc oxide and copper oxide film on the surface of pure magnesium or magnesium alloy, which can greatly improve the stability of pure magnesium or magnesium alloy and at the same time improve the stability of pure magnesium or magnesium alloy. The corrosion resistance of pure magnesium or magnesium alloy effectively slows down the degradation rate of pure magnesium or magnesium alloy. As the degradation process of pure magnesium or magnesium alloy proceeds, the zinc ions and copper ions released by the above coating can play a bactericidal effect and avoid bacterial infection.
进一步地,所述步骤S1中的预处理包括:Further, the preprocessing in step S1 includes:
对纯镁或者镁合金依次进行抛光处理、超声清洗和干燥。Pure magnesium or magnesium alloy is polished, ultrasonic cleaned and dried in sequence.
需要说明的是,上述预处理过程中,可将粘附在纯镁或镁合金表面的污染物进行清理,使得后面的离子注入过程能够顺利进行。It should be noted that during the above pretreatment process, contaminants adhering to the surface of pure magnesium or magnesium alloy can be cleaned, so that the subsequent ion implantation process can proceed smoothly.
进一步地,所述步骤S2具体包括:Further, the step S2 specifically includes:
采用配备锌阴极弧源的金属离子注入机对纯镁或镁合金进行离子注入,脉冲电压为-5~-35kV,注入压力为1~3×10
-3Pa,注入时间为1~3h。
Use a metal ion implanter equipped with a zinc cathode arc source to perform ion implantation on pure magnesium or magnesium alloy. The pulse voltage is -5~-35kV, the injection pressure is 1~3×10 -3 Pa, and the injection time is 1~3h.
进一步地,所述步骤S3具体包括:Further, the step S3 specifically includes:
采用配备铜阴极弧源的金属离子注入机对完成步骤S2的纯镁或镁合金进行离子注入,脉冲电压为-5~-35kV,注入压力为1~3×10
-3Pa,注入时间为1~3h。
Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2. The pulse voltage is -5~-35kV, the injection pressure is 1~3× 10-3 Pa, and the injection time is 1 ~3h.
进一步地,所述步骤S4具体包括:Further, the step S4 specifically includes:
使用气体注入机对完成步骤S3的纯镁或镁合金进行氧气注入:氧气流量30sccm,射频1000W,脉冲电压-20kV,脉宽150μs,脉冲频率50Hz,处理时间1~2h。Use a gas injector to inject oxygen into the pure magnesium or magnesium alloy that has completed step S3: oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150μs, pulse frequency 50Hz, processing time 1 to 2 hours.
进一步地,所述的镁合金为镁锌钙系镁合金、镁锌系镁合金、稀土系镁合金中的一种。Further, the magnesium alloy is one of a magnesium-zinc-calcium magnesium alloy, a magnesium-zinc magnesium alloy, and a rare earth magnesium alloy.
需要说明的是,本实施例并不对镁合金的具体类型作出限制,设计人员可根据实际情况选用合适的镁合金进行表面改性。It should be noted that this embodiment does not limit the specific type of magnesium alloy, and designers can select a suitable magnesium alloy for surface modification according to actual conditions.
进一步地,还包括步骤S6;Further, it also includes step S6;
S6、对形成含铜元素和锌元素的涂层的纯镁或镁合金进行清洗,再吹干保存。S6. Clean the pure magnesium or magnesium alloy that forms the coating containing copper elements and zinc elements, and then blow dry and store it.
实施例二Embodiment 2
本发明实施例中提供的一种可降解纯镁或镁合金材料,其具体采用实施例一中所述的可降解纯镁或镁合金表面改性方法得到。The degradable pure magnesium or magnesium alloy material provided in the embodiment of the present invention is specifically obtained by using the degradable pure magnesium or magnesium alloy surface modification method described in Embodiment 1.
需要说明的是,本实施例中经过表面改性方法改性后得到的纯镁或镁合金材料具良好的生物安全性,优良的力学性能,耐腐蚀性能和抗菌性能,能够满足植入材料的使用要求,且能够在基体内达到使用效果后降解消失,避免二次手术取出。It should be noted that the pure magnesium or magnesium alloy material modified by the surface modification method in this embodiment has good biological safety, excellent mechanical properties, corrosion resistance and antibacterial properties, and can meet the requirements of implant materials. Use requirements, and can be degraded and disappeared after achieving the use effect in the matrix, avoiding secondary surgical removal.
实验例一Experimental example one
本实验例中,将纯镁切割成直径10mm和厚3mm的圆片,并对其表面依次进行磨光、抛光处理、超声清洗以及干燥。采用配备锌阴极弧源的金属离子注入机将纯镁圆片进行离子注入,脉冲电压为-15kV,注入压力为1××10
-3Pa,注入时间为1h。接着采用配备铜阴极弧源的金属离子注入机对纯镁圆片进行离子注入,脉冲电压为-15kV,注入压力为1××10
-3Pa,注入时间为1h。然后使用气体注入机对完成铜元素和锌元素注入的纯镁圆片进行氧气注入:氧气流量30sccm,射频1000W,脉冲电压-20kV,脉宽150μs,脉冲频率50Hz,处理时间1h。
In this experimental example, pure magnesium is cut into discs with a diameter of 10mm and a thickness of 3mm, and the surface is polished, polished, ultrasonic cleaned and dried in sequence. Pure magnesium discs were ion implanted using a metal ion implanter equipped with a zinc cathode arc source. The pulse voltage was -15kV, the injection pressure was 1××10 -3 Pa, and the injection time was 1 hour. Then, a metal ion implanter equipped with a copper cathode arc source was used to implant ions into the pure magnesium wafer. The pulse voltage was -15kV, the injection pressure was 1××10 -3 Pa, and the injection time was 1 hour. Then use a gas injector to inject oxygen into the pure magnesium wafer that has been injected with copper and zinc elements: oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150μs, pulse frequency 50Hz, processing time 1h.
本实验例纯镁圆片的耐腐蚀性见表1,抗菌率和细胞毒性见表2。The corrosion resistance of pure magnesium discs in this experimental example is shown in Table 1, and the antibacterial rate and cytotoxicity are shown in Table 2.
实验例二Experimental example two
本实验例中,将Mg-2Zn-0.8Ca镁合金切割成直径10mm,厚3mm的圆片,对其表面依次进行磨光、抛光处理、超声清洗以及干燥。采用配备锌阴极弧源的金属离子注入机对上述镁合金圆片进行离子注入,脉冲电压为-15kV,注入压力为1××10
-3Pa,注入时间为2h。接着采用配备铜阴极弧源的金属离子注入机对镁合金圆片进行离子注入,脉冲电压为-15kV,注入压力为1××10
-3Pa,注入时间为2h。然后使用气体注入机对完成铜元素和锌元素注入的镁合金圆片进行氧气注入:氧气流量30sccm,射频1000W,脉冲电压-20kV,脉宽150μs,脉冲频率50Hz,处理时间1h。
In this experimental example, the Mg-2Zn-0.8Ca magnesium alloy was cut into discs with a diameter of 10mm and a thickness of 3mm, and the surface was polished, polished, ultrasonic cleaned and dried in sequence. A metal ion implanter equipped with a zinc cathode arc source was used to implant ions into the above-mentioned magnesium alloy discs. The pulse voltage was -15kV, the injection pressure was 1××10 -3 Pa, and the injection time was 2h. Then, a metal ion implanter equipped with a copper cathode arc source was used to implant ions into the magnesium alloy wafer. The pulse voltage was -15kV, the injection pressure was 1××10 -3 Pa, and the injection time was 2h. Then use a gas injector to inject oxygen into the magnesium alloy wafer that has been injected with copper and zinc elements: oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150μs, pulse frequency 50Hz, processing time 1h.
本实验例的镁合金圆片的耐腐蚀性见表1,抗菌率和细胞毒性见表2。The corrosion resistance of the magnesium alloy discs in this experimental example is shown in Table 1, and the antibacterial rate and cytotoxicity are shown in Table 2.
实验例三Experimental example three
本实验例中,将Mg-1Zn-0.2Nd-1Zr镁合金切割成直径10mm,厚3mm的圆片,对其表面依次进行磨光、抛光处理、超声清洗以及干燥。采用配备锌阴极弧源的金属离子注入机对镁合金圆片进行离子注入,脉冲电压为-15kV,注入压力为1××10
-3Pa,注入时间为1.5h。接着采用配备铜阴极弧源的金属离子注入机对纯镁圆片进行离子注入,脉冲电压为-15kV,注入压力为1××10
-3Pa,注入时间为1.5h。然后使用气体注入机对完成铜元素和锌元素注入的镁合金圆片进行氧气注入:氧气流量30sccm,射频1000W,脉冲电压-20kV,脉宽150μs,脉冲频率50Hz,处理时间1h。
In this experimental example, the Mg-1Zn-0.2Nd-1Zr magnesium alloy was cut into discs with a diameter of 10mm and a thickness of 3mm, and the surface was polished, polished, ultrasonic cleaned and dried in sequence. A metal ion implanter equipped with a zinc cathode arc source was used to implant ions into magnesium alloy discs. The pulse voltage was -15kV, the injection pressure was 1××10 -3 Pa, and the injection time was 1.5h. Then, a metal ion implanter equipped with a copper cathode arc source was used to implant ions into the pure magnesium wafer. The pulse voltage was -15kV, the injection pressure was 1××10 -3 Pa, and the injection time was 1.5h. Then use a gas injector to inject oxygen into the magnesium alloy wafer that has been injected with copper and zinc elements: oxygen flow 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150μs, pulse frequency 50Hz, processing time 1h.
本实验例的镁合金圆片的耐腐蚀性见表1,抗菌率和细胞毒性见表2。The corrosion resistance of the magnesium alloy discs in this experimental example is shown in Table 1, and the antibacterial rate and cytotoxicity are shown in Table 2.
表1:各实验例中的纯镁圆片和镁合金圆片在hanks溶液中浸泡30天的年腐蚀速率Table 1: Annual corrosion rate of pure magnesium discs and magnesium alloy discs soaked in Hanks solution for 30 days in each experimental example
| 年腐蚀速率(mm/y)Annual corrosion rate (mm/y) |
对照组(纯镁没有经过表面改性)Control group (pure magnesium without surface modification) | 4±0.54±0.5 |
实验例1Experimental example 1 | 2.3±0.32.3±0.3 |
实验例2Experimental example 2 | 1.8±0.21.8±0.2 |
实验例3Experimental example 3 | 2.2±0.22.2±0.2 |
表2:各实验例中的纯镁圆片和镁合金圆片的抗菌率和细胞毒性Table 2: Antibacterial rate and cytotoxicity of pure magnesium discs and magnesium alloy discs in each experimental example
| 抗菌率(%)Antibacterial rate (%) | 细胞毒性Cytotoxicity |
对照组(纯镁没有经过表面改性)Control group (pure magnesium without surface modification) | 1010 | 1级Level 1 |
实验例1Experimental example 1 | 9090 | 1级Level 1 |
实验例2Experimental example 2 | 9898 | 1级Level 1 |
实验例3Experimental example 3 | 9595 | 1级Level 1 |
由表1和表2可以看出,经过本发明表面改性方法改性后的纯镁或镁合金材料具有良好的耐腐蚀性和优异的抗菌性能。能够满足植入材料的使用要求,且能够在基体内达到使用效果后降解消失,避免二次手术取出。It can be seen from Table 1 and Table 2 that the pure magnesium or magnesium alloy material modified by the surface modification method of the present invention has good corrosion resistance and excellent antibacterial properties. It can meet the requirements for the use of implant materials, and can degrade and disappear after achieving the use effect in the matrix, avoiding secondary surgical removal.
以上对本发明所提供的一种可降解纯镁或镁合金表面改性方法及纯镁或镁合金材料进行了详细介绍,对于本领域的一般技术人员,依据本发明实施例的思想,在具体实施方式及应用范围上均会有改变之处,综上所述,本说明书内容不应理解为对本发明的限制。The above is a detailed introduction to a degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy materials provided by the present invention. For those of ordinary skill in the art, based on the ideas of the embodiments of the present invention, in the specific implementation There may be changes in the manner and scope of application. In summary, the content of this specification should not be construed as limiting the present invention.
Claims (8)
- 一种可降解纯镁或镁合金表面改性方法,其特征在于,包括以下步骤:A method for surface modification of degradable pure magnesium or magnesium alloy, which is characterized by including the following steps:S1、将纯镁或镁合金进行预处理;S1. Preprocess pure magnesium or magnesium alloy;S2、采用配备锌阴极弧源的金属离子注入机对纯镁或镁合金进行离子注入;S2. Use a metal ion implanter equipped with a zinc cathode arc source to perform ion implantation on pure magnesium or magnesium alloy;S3、采用配备铜阴极弧源的金属离子注入机对完成步骤S2的纯镁或镁合金进行离子注入;S3. Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2;S4、使用气体注入机对完成步骤S3的纯镁或镁合金进行氧气注入;S4. Use a gas injector to inject oxygen into the pure magnesium or magnesium alloy that has completed step S3;S5、纯镁或镁合金表面形成含铜元素和锌元素的涂层。S5. A coating containing copper and zinc elements is formed on the surface of pure magnesium or magnesium alloy.
- 根据权利要求1所述的可降解纯镁或镁合金表面改性方法,其特征在于,所述步骤S1中的预处理包括:The method for surface modification of degradable pure magnesium or magnesium alloy according to claim 1, characterized in that the pretreatment in step S1 includes:对纯镁或者镁合金依次进行抛光处理、超声清洗和干燥。Pure magnesium or magnesium alloy is polished, ultrasonic cleaned and dried in sequence.
- 根据权利要求1所述的可降解纯镁或镁合金表面改性方法,其特征在于,所述步骤S2具体包括:The method for surface modification of degradable pure magnesium or magnesium alloy according to claim 1, characterized in that the step S2 specifically includes:采用配备锌阴极弧源的金属离子注入机对纯镁或镁合金进行离子注入,脉冲电压为-5~-35kV,注入压力为1~3×10 -3Pa,注入时间为1~3h。 Use a metal ion implanter equipped with a zinc cathode arc source to perform ion implantation on pure magnesium or magnesium alloy. The pulse voltage is -5~-35kV, the injection pressure is 1~3×10 -3 Pa, and the injection time is 1~3h.
- 根据权利要求3所述的可降解纯镁或镁合金表面改性方法,其特征在于,所述步骤S3具体包括:The method for surface modification of degradable pure magnesium or magnesium alloy according to claim 3, characterized in that the step S3 specifically includes:采用配备铜阴极弧源的金属离子注入机对完成步骤S2的纯镁或镁合金进行离子注入,脉冲电压为-5~-35kV,注入压力为1~3×10 -3Pa,注入时间为1~3h。 Use a metal ion implanter equipped with a copper cathode arc source to ion implant the pure magnesium or magnesium alloy that has completed step S2. The pulse voltage is -5~-35kV, the injection pressure is 1~3× 10-3 Pa, and the injection time is 1 ~3h.
- 根据权利要求1所述的可降解纯镁或镁合金表面改性方法,其特征在于,所述步骤S4具体包括:The method for surface modification of degradable pure magnesium or magnesium alloy according to claim 1, characterized in that the step S4 specifically includes:使用气体注入机对完成步骤S3的纯镁或镁合金进行氧气注入:氧气流量30sccm,射频1000W,脉冲电压-20kV,脉宽150μs,脉冲频率50Hz,处理时间1~2h。Use a gas injector to inject oxygen into the pure magnesium or magnesium alloy that has completed step S3: oxygen flow rate 30sccm, radio frequency 1000W, pulse voltage -20kV, pulse width 150μs, pulse frequency 50Hz, processing time 1 to 2 hours.
- 根据权利要求1所述的可降解纯镁或镁合金表面改性方法,其特征在于,所述的镁合金为镁锌钙系镁合金、镁锌系镁合金、稀土系镁合金中的一种。The method for surface modification of degradable pure magnesium or magnesium alloy according to claim 1, characterized in that the magnesium alloy is one of magnesium zinc calcium series magnesium alloy, magnesium zinc series magnesium alloy and rare earth series magnesium alloy. .
- 根据权利要求1所述的可降解纯镁或镁合金表面改性方法,其特征在 于,还包括步骤S6;The method for surface modification of degradable pure magnesium or magnesium alloy according to claim 1, characterized in that it also includes step S6;S6、对形成含铜元素和锌元素的涂层的纯镁或镁合金进行清洗,再吹干保存。S6. Clean the pure magnesium or magnesium alloy that forms the coating containing copper elements and zinc elements, and then blow dry and store it.
- 一种纯镁或镁合金材料,其特征在于,采用如权利要求1至7任一项所述的可降解纯镁或镁合金表面改性方法得到。A pure magnesium or magnesium alloy material, characterized in that it is obtained by using the degradable pure magnesium or magnesium alloy surface modification method as described in any one of claims 1 to 7.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210493489.5A CN115522175A (en) | 2022-05-07 | 2022-05-07 | Degradable pure magnesium or magnesium alloy surface modification method and pure magnesium or magnesium alloy material |
CN202210493489.5 | 2022-05-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023216521A1 true WO2023216521A1 (en) | 2023-11-16 |
Family
ID=84696552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/128189 WO2023216521A1 (en) | 2022-05-07 | 2022-10-28 | Surface modification method for degradable pure magnesium or magnesium alloy, and pure magnesium or magnesium alloy material |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115522175A (en) |
WO (1) | WO2023216521A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117448741A (en) * | 2023-12-26 | 2024-01-26 | 泓欣科创生物科技(北京)有限公司 | Preparation method of coating for controlling degradation rate of biomedical material magnesium alloy and biomedical material magnesium alloy |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116328025B (en) * | 2023-05-29 | 2023-08-08 | 北京大学第三医院(北京大学第三临床医学院) | Medical implant material, implant and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005060786A (en) * | 2003-08-15 | 2005-03-10 | Japan Science & Technology Agency | Microorganism corrosion-resistant alloy plating, and method of producing microorganism corrosion-resistant alloy plating |
CN109652771A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of bone implant zinc-copper coating and preparation method thereof |
CN109666892A (en) * | 2017-10-13 | 2019-04-23 | 香港大学深圳医院 | The preparation method of the magnesium alloy of the active nano size Titania protective film in surface |
CN112609068A (en) * | 2020-12-10 | 2021-04-06 | 常州大学 | Composite strengthening method for improving stress corrosion resistance of light alloy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107304472B (en) * | 2016-04-18 | 2019-06-11 | 中国科学院上海硅酸盐研究所 | Have both the medical titanium-based composite coat and preparation method thereof of Bone Defect Repari function and anti-microbial property |
-
2022
- 2022-05-07 CN CN202210493489.5A patent/CN115522175A/en active Pending
- 2022-10-28 WO PCT/CN2022/128189 patent/WO2023216521A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005060786A (en) * | 2003-08-15 | 2005-03-10 | Japan Science & Technology Agency | Microorganism corrosion-resistant alloy plating, and method of producing microorganism corrosion-resistant alloy plating |
CN109652771A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of bone implant zinc-copper coating and preparation method thereof |
CN109666892A (en) * | 2017-10-13 | 2019-04-23 | 香港大学深圳医院 | The preparation method of the magnesium alloy of the active nano size Titania protective film in surface |
CN112609068A (en) * | 2020-12-10 | 2021-04-06 | 常州大学 | Composite strengthening method for improving stress corrosion resistance of light alloy |
Non-Patent Citations (1)
Title |
---|
GAO ZHI-HENG: "Corrosion Characteristics and Protection Techniques for Mg Alloys", SURFACE TECHNOLOGY., vol. 45, no. 3, 1 March 2016 (2016-03-01), pages 169 - 177, XP093107568, DOI: 10.16490/j.cnki.issn.1001-3660.2016.03.028 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117448741A (en) * | 2023-12-26 | 2024-01-26 | 泓欣科创生物科技(北京)有限公司 | Preparation method of coating for controlling degradation rate of biomedical material magnesium alloy and biomedical material magnesium alloy |
CN117448741B (en) * | 2023-12-26 | 2024-03-22 | 泓欣科创生物科技(北京)有限公司 | Preparation method of coating for controlling degradation rate of biomedical material magnesium alloy and biomedical material magnesium alloy |
Also Published As
Publication number | Publication date |
---|---|
CN115522175A (en) | 2022-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023216521A1 (en) | Surface modification method for degradable pure magnesium or magnesium alloy, and pure magnesium or magnesium alloy material | |
US5474797A (en) | Bactericidal coatings for implants | |
US5520664A (en) | Catheter having a long-lasting antimicrobial surface treatment | |
US20190083685A1 (en) | Degradable zinc base alloy implant material and preparation method and use thereof | |
US10675380B2 (en) | Nano-textured biocompatible antibacterial film | |
CN103498129B (en) | A kind of iron ion injects deposition carries out surface modification method to biological degradation Magnesium and magnesium alloys | |
EP2407183A1 (en) | Degradable stent | |
CN111424202A (en) | Degradable magnesium alloy in-situ composite anastomosis nail and preparation method thereof | |
CN113101414B (en) | Artificial joint prosthesis with anti-infection function | |
CN112391600A (en) | Corrosion-resistant medical magnesium alloy surface hydroxyapatite coating and preparation method thereof | |
US20170043055A1 (en) | Materials with modified surfaces and methods of manufacturing | |
Zhao et al. | In vivo research on Cu-bearing ureteral stent | |
WO1998009667A1 (en) | Antimicrobial medical devices and methods of production and use | |
US20130066417A1 (en) | Biodegradable stent | |
CN111235476A (en) | Degradable anti-infection and anti-calculus Fe-Cu series alloy suitable for urinary implant material | |
RU2632761C1 (en) | Orthopedic implant from titanium and stainless steel with antiadhesive antibacterial coating | |
WO2021243684A1 (en) | Degradable magnesium alloy in-situ composite staple and preparation method therefor | |
US12109325B2 (en) | Ductile coating for an implant component | |
RU2651837C1 (en) | Method of anti-adhesive, bio-compatible, and bacteriostatic coating on the basis of carbon application onto metallic, polymer and textile products of medical purpose | |
Alkhateeb et al. | Efficacy of Hyaluronic Acid in Relieving Post-implantation Pain: A Split-Mouth Randomized Controlled Trial | |
CN110694120A (en) | Biomedical degradable material and preparation method thereof | |
CN115054738B (en) | Degradable zinc alloy nasal sinus support | |
RU2724277C1 (en) | Processing unit for applying nanocarbon coatings on surfaces of medical devices or parts thereof having antibacterial and biocompatible properties | |
Zhong et al. | Novel Biodegradable Antimicrobial Composite Scaffold by Coating Type I Collagen Scaffold with Pepsin-Degraded SIS Extraction | |
JP2008080113A (en) | Medical instrument and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22941458 Country of ref document: EP Kind code of ref document: A1 |